5-36284500-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_145000.5(RANBP3L):c.92-13189C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.953 in 152,328 control chromosomes in the GnomAD database, including 69,457 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.95 ( 69457 hom., cov: 33)
Consequence
RANBP3L
NM_145000.5 intron
NM_145000.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.925
Publications
0 publications found
Genes affected
RANBP3L (HGNC:26353): (RAN binding protein 3 like) Enables SMAD binding activity. Predicted to be involved in several processes, including mesenchymal cell differentiation involved in bone development; negative regulation of osteoblast differentiation; and positive regulation of myoblast differentiation. Predicted to be part of nuclear pore. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.983 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RANBP3L | ENST00000296604.8 | c.92-13189C>A | intron_variant | Intron 1 of 13 | 1 | NM_145000.5 | ENSP00000296604.3 | |||
| RANBP3L | ENST00000502994.5 | c.92-13189C>A | intron_variant | Intron 1 of 14 | 2 | ENSP00000421853.1 | ||||
| RANBP3L | ENST00000515759.5 | c.92-13189C>A | intron_variant | Intron 1 of 9 | 2 | ENSP00000421149.1 | ||||
| RANBP3L | ENST00000505865.1 | c.92-13189C>A | intron_variant | Intron 2 of 5 | 4 | ENSP00000427147.1 |
Frequencies
GnomAD3 genomes AF: 0.953 AC: 145064AN: 152210Hom.: 69421 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
145064
AN:
152210
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.953 AC: 145154AN: 152328Hom.: 69457 Cov.: 33 AF XY: 0.950 AC XY: 70794AN XY: 74486 show subpopulations
GnomAD4 genome
AF:
AC:
145154
AN:
152328
Hom.:
Cov.:
33
AF XY:
AC XY:
70794
AN XY:
74486
show subpopulations
African (AFR)
AF:
AC:
38773
AN:
41568
American (AMR)
AF:
AC:
13797
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
3433
AN:
3472
East Asian (EAS)
AF:
AC:
3542
AN:
5176
South Asian (SAS)
AF:
AC:
4621
AN:
4830
European-Finnish (FIN)
AF:
AC:
10425
AN:
10626
Middle Eastern (MID)
AF:
AC:
288
AN:
294
European-Non Finnish (NFE)
AF:
AC:
67321
AN:
68040
Other (OTH)
AF:
AC:
2043
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
311
622
933
1244
1555
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
908
1816
2724
3632
4540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2972
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.